$5.9 Billion Acquisition

New CMO and New Stock Record High

Dear subscribers,

We hope this newsletter finds you well. Here's a roundup of the latest news and updates from the world of healthcare and biotech funding.

U.S total funding of $3.5 billion across 129 deals with 6 companies and 16 Acquisitions Recorded for a total of $8.1 Billion

The biggest acquisition was IVERIC Bio which was acquired by Astellas Pharma for $5.9 Billion.

Dexcom managed to raise $1 billion Post-IPO Debt while Zipline raised a Series For $330 Million.